CLB
$15.8
Revenue | $128.21Mn |
Net Profits | $6.46Mn |
Net Profit Margins | 5.04% |
Core Laboratories Inc’s revenue jumped 0.5% since last year same period to $128.21Mn in the Q4 2023. On a quarterly growth basis, Core Laboratories Inc has generated 2.29% jump in its revenue since last 3-months.
Core Laboratories Inc’s net profit fell -4.27% since last year same period to $6.46Mn in the Q4 2023. On a quarterly growth basis, Core Laboratories Inc has generated -30.18% fall in its net profits since last 3-months.
Core Laboratories Inc’s net profit margin fell -4.74% since last year same period to 5.04% in the Q4 2023. On a quarterly growth basis, Core Laboratories Inc has generated -31.74% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.16 |
EPS Estimate Current Year | 0.16 |
Core Laboratories Inc’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a -15.79% fall from last quarter’s estimates.
Core Laboratories Inc’s earning per share (EPS) estimates for the current year stand at 0.16.
Earning Per Share (EPS) | 0.19 |
Dividend Per Share (DPS) | 0.01 |
Core Laboratories Inc’s earning per share (EPS) jumped 0% since last year same period to 0.19 in the Q1 2024. This indicates that the Core Laboratories Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Core Laboratories Inc declared 0.01 dividend per share during the earnings announcement for Q1 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-24 | 0.16 | 0.19 | 18.75% |